Objective: To evaluate the diagnostic accuracy of cerebrospinal fluid (CSF)-based routine clinical examinations for post-neurosurgical bacterial meningitis (PNBM) in multicenter post-neurosurgical patients. Methods: The diagnostic accuracies of routine examinations to distinguish between PNBM and post-neurosurgical aseptic meningitis (PNAM) were evaluated by determining the values of the area under the curve (AUC) of the receiver operating characteristic curve in a retrospective analysis of post-neurosurgical patients in four centers.
| INTRODUC TI ON
Post-neurosurgical meningitis (PNM), a common complication of neurosurgical procedures, has an incidence rate of 0.3%-25%. 1 PNM significantly affects the length of hospital stay (LOS), increases the cost, decreases the success rate of neurosurgery, and increases patients' mortality rate. PNM can cause approximately 35% mortality. 2 PNM has been mainly divided into post-neurosurgical bacterial meningitis (PNBM) and post-neurosurgical aseptic meningitis (PNAM). 3 The pathogenesis and treatment for PNBM and PNAM are completely different. The main cause of PNBM is infections induced by pathogenic bacteria; the onset of PNBM is rapid, and antibiotics are required for treatment. Scattered bone fragments or tumor antigens produced during neurosurgery may be the cause of PNAM, and no antibiotics are required for its treatment. 4 PNBM and PNAM always share some physical signs and clinical symptoms, including mental status changes, neck stiffness, headache, fever, and vomiting, which do not sufficiently specify the clinical manifestations of both meningitis forms to diagnose PNBM. 5 Given these influencing factors, rapid diagnostic methods are needed urgently to provide more diagnostic options and evaluate the efficacy of antibiotic drugs.
Presently, regardless of the Infectious Diseases Society of America (IDSA) 6 and Centres for Disease Control and Prevention (CDC) 7 
| MATERIAL S AND ME THODS

| Study design and data abstraction
This study was first performed on patients suspected to have PNM and hospitalized during 2012-2018 at Beijing Tiantan Hospital, a tertiary hospital with 13 000 neurosurgical operations conducted annually. All the patients who underwent post-neurosurgery during this period were eligible for this study. The variables were retrospectively obtained from the databases of clinical laboratory information system, 
| Definition of neurosurgical meningitis
| Inclusion and exclusion criteria
This study performed as a gold standard for the diagnosis of meningitis in groups of PNBM and PNAM. 9 The inclusion criteria were as follows: PNBM when all three criteria were met. The PAM patients required a diagnostic lumbar puncture, but did not receive postoperative antibiotic treatments. The specific criteria are as follows: (a) abnormalities in laboratory tests related to CSF and (b) diagnostic criteria for bacterial meningitis not met. 10 Patients who were immunocompromised and had CSF shunt infections, had coagulase-negative staphylococci infection, or showed the presence of cryptococcal antigen, intracranial masses, and brain abscesses were excluded from the study. 11
| Specimen collection
The CSF samples of all the patients were collected on the day when the body temperature exceeded 38.3°C. CSF specimens were obtained by lumbar puncture, lumbar cistern drainage, ventricular drainage, or ventriculoscopy. Blood specimens were obtained by the conventional venous blood collection method.
| Statistical methods
All the variables were analyzed using SPSS software version 20 (IBM). Continuous data were expressed as mean ± SD or median (25%, 75%), whereas categorical data were expressed as numbers and percentages. Continuous variables were analyzed by nonparametric Mann-Whitney U test or Student's t test when appropriate, and chi-square or Fisher's exact test was performed for the categorical data. Univariate analysis was employed to calculate the P values for all variables; a multivariate algorithm was performed to take into account differences between the two groups by using a logistic regression. All the variables whose P was < .05 were embedded into the one fitting variable. 12 Diagnosis accuracy of the fitted variable was evaluated by area under the curve (AUC) of the receiver operating characteristic (ROC) curve analyses, and the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Youden score, and cutoff values were also calculated. The established algorithm was validated by the data of the patients at four neurosurgical centers. 
| RE SULTS
| Patient characteristics and microbiological results of the samples
| Univariate analysis of the parameters
We evaluated the diagnostic accuracy of these variables with a statistically significant difference. The result of the univariate analysis for each variable is shown in Table 2 . Among these tests, in general, CSF variables performed better than blood variables. All the CSF biomarkers, including C-Cell (10 6 /L), C-Leu (10 6 /L), C-Neu (%), C-Glu (mmol/L), C-Pro (mg/dL), C-Cl -(mmol/L), and B-Glu (mmol/L), showed a statistically significant difference between the PNBM group and the PNAM group.
| Multivariate analysis of the parameters
We included all the factors with P value < .2 in the univariate analysis into the logistic multivariate analysis. C-Leu, C-Glu, B-Glu, C/B-Glu, and C-Lac were determined as the parameters for the algorithm's construction (Table 3) . Simultaneously, an algorithm was constructed with the analysis, which is a classification method that integrated the five abovementioned biomarkers to maximize the capacity for differentiating between the PNBM and 
| Verification of the multivariate algorithm
The fitted variable and the five biomarkers above, including C-Leu verification (Table 4 and Figure 1 ). Among these biomarkers, C-Leu at a cutoff value of 577.5*10 6 /L had the highest specificity (83.6%), and C-Lac had the best sensitivity (82.4%) and PPV (78.0%). The results of the ROC curve of the fitted biomarkers, which formed in the multivariate algorithm, are shown in Table 5 . The AUC of the fitted variable was 0.907, and the sensitivity, specificity, PPV, and NPV were greater than 80.0%. The cutoff of the fitted variable is 0.505. The AUC indicated that the fitted variable was a much better biomarker for distinguishing PNBM from PNAM.
| Verification by the hypothetical cohort of 1000 patients
In Table 6 . Figure 2 .
| Multicenter verification of the algorithms
The algorithm was verified by these 274 confirmed PNM patients from four centers in northern China, and the calculated F value was compared with the cutoff (shown in Table 5 ) value calculated by the ROC curve. Patients whose biomarkers' values were greater than the 0.505(cutoff value) of the algorithm were classified as PNBM, and patients whose F values were less than the 0.505 of the algorithm were classified as PNAM. The results are shown in Table 7 . The predicted values of 70 PNBM patients were greater than the cutoff value, and the positive concordance rate was 75.3%. The results of 181 patients with PNAM showed that 172 patients were correctly identified; the negative concordance rate was 95.0%, and the overall concordance rate of the algorithm was 88.6%.
| D ISCUSS I ON
PNBM can be diagnosed through clinical symptoms, CSF laboratory biomarker analysis, and Gram staining with some uncertainty, and ideally through CSF bacterial culture. The analysis of CSF laboratory biomarkers is one of the most pivotal methods to diagnose PNBM. 13 However, many studies have reported that routine infection markers such as CSF or blood biomarkers are not diagnostically optimal due to low specificity, 1 and therefore, PNBM may not be accurately diagnosed. In our current study, we evaluated the diagnostic accuracy of parallelly combined routine CSF and blood tests for PNBM. An algorithm that can distinguish PNBM from PNAM was established, and a multicenter verification was also performed. The best highlight of this study is that we implemented the most common clinical diagnosis indicators, such as the CSF/blood glucose ratio, lactate, and CSF leukocyte count to make precise diagnosis of PNBM, and our algorithm that passes through verification and confirmation could facilitate delivering a more accurate PNBM diagnosis.
At present, there are many reports on the differentiation between PNBM and PNAM, but almost all the reports on meningitis have included relevant markers, such as C-Leu, for an auxiliary diagnosis. 4, 14 This grouping method can expand the number of enrolled patients with PNBM, but it is also inevitable to include patients with non-bacterial meningitis. This study grouped meningitis based on the gold standard of infection and clinical symptoms, which can effectively avoid the inclusion of non-bacterial meningitis and have higher clinical value. 15 In this study, we first determined the rele- Tiantan Hospital, the difference in 11 markers, including eight CSF and three blood markers, in the two groups of patients with meningitis was statistically significant. The AUC showed that the diagnostic efficacy of CSF markers was superior to blood markers.
C-Leu was not the most effective biomarker for the diagnosis of PNBM (AUC = 0.754) because of its high sensitivity (83.6%) and low specificity (56.0%, <60%). Compared with CSF leukocyte-related markers, C-Glu was more effective in diagnosing PNBM, especially C/B-Glu, which is the most effective diagnostic indicator of all single markers (AUC = 0.820). The reason may be that there is a consumption of glucose in PNBM, but PNAM patients only experience an inflammatory reaction; thus, the difference between the two is actually significant. 16 In addition to routine markers, C-Lac is the second variable for diagnostic efficacy (AUC = 0.791).
In a prospective study, C-Lac can effectively distinguish PNBM from PNAM when its concentration is greater than 6 μmol/L, and the value of C-Lac was determined to be 4-6 μmol/L for PNBM treatment period, and <2 μmol/L for PNAM. 17 The main limitation of this study is that it comprised routine examinations, but clinical symptoms such as body temperature and age were not considered. In addition, infection markers such as procalcitonin, interleukin-6, and C-reactive protein were not discussed in this study. In our future studies, new biomarkers will be gradually included as variables of the algorithm in order to further increase the sensitivity and specificity of this method.
| CON CLUS ION
To summarize, routine biomarkers such as C/B-Glu, C-Lac, C-Glu, C-Leu, and B-Glu can be used for the auxiliary diagnosis of PNBM.
In this study, multicenter research was performed to show that by combining the five abovementioned biomarkers, we can effectively improve the efficacy of PNBM diagnosis and can speed up the entire diagnostic procedure.
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